Harmony Biosciences Holdings Inc (HRMY)

34.31 -0.87 (-2.47%) USD  |  NASDAQ  |  Jan 08, 12:08
More

Harmony Biosciences Holdings SG&A Expense (Quarterly): 56.16M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for HRMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Arrowhead Pharmaceuticals Inc 25.79M
Incyte Corp 309.20M
Regeneron Pharmaceuticals Inc 714.40M
Vertex Pharmaceuticals Inc 371.80M
Avidity Biosciences Inc 23.27M